[go: up one dir, main page]

FR2389380A1 - - Google Patents

Info

Publication number
FR2389380A1
FR2389380A1 FR7713255A FR7713255A FR2389380A1 FR 2389380 A1 FR2389380 A1 FR 2389380A1 FR 7713255 A FR7713255 A FR 7713255A FR 7713255 A FR7713255 A FR 7713255A FR 2389380 A1 FR2389380 A1 FR 2389380A1
Authority
FR
France
Prior art keywords
interferon activity
products
preparations
medicaments
brought
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7713255A
Other languages
French (fr)
Other versions
FR2389380B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR7713255A priority Critical patent/FR2389380B1/fr
Priority to JP5243578A priority patent/JPS53139714A/en
Priority to CH473978A priority patent/CH633716A5/en
Priority to DE19782819297 priority patent/DE2819297A1/en
Priority to GB17225/78A priority patent/GB1601744A/en
Publication of FR2389380A1 publication Critical patent/FR2389380A1/fr
Application granted granted Critical
Publication of FR2389380B1 publication Critical patent/FR2389380B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne la séparation de produits à activité interféron de préparations les renfermant Ces préparations sont mises en contact avec une phase comprenant au moins un composé du type polynucléotide. Application à la préparation de produits purifiés à activité interféron utilisables comme médicaments.The invention relates to the separation of products with interferon activity from preparations containing them. These preparations are brought into contact with a phase comprising at least one compound of the polynucleotide type. Application to the preparation of purified products with interferon activity which can be used as medicaments.

FR7713255A 1977-05-02 1977-05-02 Expired FR2389380B1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR7713255A FR2389380B1 (en) 1977-05-02 1977-05-02
JP5243578A JPS53139714A (en) 1977-05-02 1978-05-02 Method for separating interferon active substance from medical preparation containing said substace and purifying same * purified substance and utilizing same as medicine
CH473978A CH633716A5 (en) 1977-05-02 1978-05-02 Method for separating and purifying products having interferon activity, purified preparations having interferon activity and use of the preparations
DE19782819297 DE2819297A1 (en) 1977-05-02 1978-05-02 PROCESS FOR SEPARATION AND CLEANING OF PRODUCTS WITH INTERFERONACTIVITY, THE PRODUCTS THEREOF AND THEIR USE AS ACTIVE INGREDIENTS
GB17225/78A GB1601744A (en) 1977-05-02 1978-05-02 Processes for the purification of interferon certain new and useful intermediates formed therein the purified interferon thus produced and pharmaceutical compositions containing

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7713255A FR2389380B1 (en) 1977-05-02 1977-05-02

Publications (2)

Publication Number Publication Date
FR2389380A1 true FR2389380A1 (en) 1978-12-01
FR2389380B1 FR2389380B1 (en) 1980-02-29

Family

ID=9190209

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7713255A Expired FR2389380B1 (en) 1977-05-02 1977-05-02

Country Status (5)

Country Link
JP (1) JPS53139714A (en)
CH (1) CH633716A5 (en)
DE (1) DE2819297A1 (en)
FR (1) FR2389380B1 (en)
GB (1) GB1601744A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027262A2 (en) * 1979-10-12 1981-04-22 E.I. Du Pont De Nemours And Company Purification of interferon

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN150740B (en) * 1978-11-24 1982-12-04 Hoffmann La Roche
FI77877C (en) * 1979-04-20 1989-05-10 Technobiotic Ltd Process for the preparation and purification of human Le-shaped interferon protein.
US6410697B1 (en) 1979-04-20 2002-06-25 Schering Corporation Process for purifying human leukocyte interferon
US4362155A (en) * 1981-03-24 1982-12-07 Skurkovich Simon V Method and apparatus for the treatment of autoimmune and allergic diseases

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0027262A2 (en) * 1979-10-12 1981-04-22 E.I. Du Pont De Nemours And Company Purification of interferon
EP0027262A3 (en) * 1979-10-12 1981-11-25 E.I. Du Pont De Nemours And Company Purification of interferon

Also Published As

Publication number Publication date
GB1601744A (en) 1981-11-04
CH633716A5 (en) 1982-12-31
FR2389380B1 (en) 1980-02-29
DE2819297A1 (en) 1978-11-16
JPS53139714A (en) 1978-12-06

Similar Documents

Publication Publication Date Title
NL930112I2 (en) Benzazepine-2-ones, methods of preparation thereof, pharmaceutical preparations containing these compounds, as well as the compounds for therapeutic use.
NZ214612A (en) Piperazine derivatives and pharmaceutical compositions
ATE22562T1 (en) 6-SUBSTITUTE S-TRIAZOLO(3,4-A)PHTHALAZINE DERIVATIVES.
ZA851552B (en) Benzisoselenazolethiones,processes for their preparation and pharmaceutical products containing these compounds
PH23778A (en) Labdan compounds,pharmaceutical compositions and use
FR2362834A1 (en) NEW 6-HEMICETAL OR 6-CETO DERIVATIVES OF PROSTAGLANDIN, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
SG49228A1 (en) Use of 2-amino-6-A-propyl-amino-4,5,6,7- tetrahydrobenzothiazole(pramipexol) as a antidepressant activity
NO814424L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITIES 5,5`-AZOBIS-SALICYLIC ACID COMPOUNDS.
ES517857A1 (en) Sulphonamides as herbicides
IT8119673A0 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OSTEOPATHIES.
IT1207514B (en) REPLACED PROSTAGLANDIN TETRAIDROTIENIL ANALOGS.
FR2389380A1 (en)
NZ241099A (en) Difluorostatone analogues and derivatives and pharmaceutical compositions
FR2379533A1 (en) TETRAZOLYLCARBAMOYLQUINOLEINS FOR USE AS MEDICINAL PRODUCTS AND THEIR PREPARATION
NZ213059A (en) Recovery of products from barley, processes for the same
IT8620208A0 (en) SUBSTITUTED 7-OXABICICHLOHEPTANETHERS AS PROSTAGLANDIN ANALOGUES AND RELATED PHARMACEUTICAL COMPOSITIONS.
FR2381035A1 (en) SUBSTITUTES USEFUL AS MEDICINES AND METHODS FOR THEIR PREPARATION
FR2359120A1 (en) NEW POLYPEPTIDIC COMPOUNDS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINAL PRODUCTS
FR2359154A1 (en) PEPTIDIC DERIVATIVES USEFUL AS MEDICINAL PRODUCTS AND PROCESS FOR THEIR PREPARATION
ES8201162A1 (en) Novel aldehyde adducts of triamterene and a pharmaceutical composition containing the same.
IT1208493B (en) ANALOGS OF OXAPROSTAGLANDIN 7-OXABICYCLEPTANE REPLACED.
DE2861247D1 (en) Novel prostaglandin compounds, processes for the preparation thereof and pharmaceutical compositions containing them
FR2355846A1 (en) PENICILLIN ESTERS FOR USE AS MEDICINAL PRODUCTS
FR2426052A1 (en) NITROFURYL-VINYLENIC COMPOUNDS, NEW ANTITUMOR DRUGS
FR2423491A1 (en) NITROGENIC HETEROCYCLIC COMPOUNDS, IN PARTICULAR N-IMIDAZOLYLAMINO-ISO-INDOLINES, AND MEDICINAL PRODUCTS CONTAINING IT

Legal Events

Date Code Title Description
ST Notification of lapse